CLY

CLINDAMYCIN

Find entries where: CLY

is present as a standalone ligand in 6 entries

Find related ligands:

Chemical Component Summary
Name	CLINDAMYCIN
Identifiers	(1R,2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-oxan-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide
Formula	C₁₈ H₃₃ Cl N₂ O₅ S
Molecular Weight	424.983
Type	NON-POLYMER
Isomeric SMILES	CCC[C@@H]1C[C@H]([N@@](C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl
InChI	InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9-,10+,11-,12+,13-,14+,15+,16+,18+/m0/s1
InChIKey	KDLRVYVGXIQJDK-AWPVFWJPSA-N

Chemical Details
Formal Charge	0
Atom Count	60
Chiral Atom Count	9
Bond Count	61
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB01190
Name	Clindamycin
Groups	vet_approved approved
Description	Clindamycin is a semi-synthetic lincosamide antibiotic used in the treatment of a variety of serious infections due to susceptible microorganisms[L11599,L11596] as well as topically for acne vulgaris.[L11593] It has a relatively narrow spectrum of activity that includes anaerobic bacteria as well as gram-positive cocci and bacilli and gram-negative bacilli.[A190621] Interestingly, clindamycin appears to carry some activity against protozoans, and has been used off-label in the treatment of toxoplasmosis, malaria, and babesiosis.[A190657] Clindamycin is derived from, and has largely replaced, [lincomycin], a naturally occurring lincosamide and the eponymous member of this antibiotic class, due to its improved properties over the parent compound. The name lincomycin is derived from Lincoln, Nebraska, where it was first isolated from _Streptomyces lincolnensis_ found in a soil sample.[A190621]
Synonyms	Clindamycin hydrochloride 7-CDL Clindamycin palmitate hydrochloride 7(S)-Chloro-7-deoxylincomycin Clindamicina Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside Clindamycine Clindamycinum Clindamycin phosphate Clindamycin
Brand Names	Jamp Clindamycin Ava-clindamycin Clindamycine-300 Duac Mylan-clindamycin Dalacin C 150 mg Clindamycin Phosphate and Benzoyl Peroxide Clindamycin Phosphate and Benzoyl Peroxide Clindamycin Phoaphate Topical USP, 1% Neuac Dalacin Vaginal Cream Clindamycin 1% / Sodium Sulfacetamide Monohydrate 5% / Tretinoin 0.025% Clindoxyl Adv Gel Benzoyl Peroxide 2.5%, Clindamycin Phosphate 1%, Niacinamide 2% / Tretinoin 0.05% Benzaclin Clindamycin Phosphate Topical Solution USP Teva-clindamycin Clindamycin 1% / Niacinamide 2% / Tazarotene 0.05% Ziana Benzoyl Peroxide 2.5% / Clindamycin 1% / Niacinamide 4% Nra-clindamycin Clindesse Clindavix Clindacin P Clindamycin Injection In 5% Dextrose Acanya Clindamycin Palmitate Hydrochloride (Pediatric) Clindamycin Phosphate and Tretinoin Gel 1.2%/0.025% Cleocin T Xaciato PMS-clindamycin Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Tretinoin 0.05% Ratio-clindamycin Capsules-150mg Clindamycin Injection Sdz Clindamycin 1% / Niacinamide 4% / Tretinoin 0.05% Clindamycin phosphate and benzoyl peroxide Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Tretinoin 0.1% Clindamycin Palmitate Hydrochloride (pediatric) Dalacin C Phosphate Clindamycin Phosphate Clindamycin Palmitate Hydrochloride Clindamycin Injection USP Apo-clindamycin Clindamycin Injection, USP NuCaraClinPAK Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Spironolactone 2% / Tretinoin 0.05% Clindamycin 1% / Niacinamide 4% CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric) Evoclin Dalacin C 300 mg Clindamycin Phosphate 1.2% and Tretinoin 0.025% Cleocin Pediatric Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Spironolactone 2% Clindamycin Phosphate and Benzoyl Peroxide Clindamycine-150 Veltin Dalacin T 1% Clindap-T Dalacin C Flavoured Granules Cleocin Clindamycin HCL Clindamycin Phosphate Topical Solution USP, 1% Clindets Clindasol Cleocin Hydrochloride Priva-clindamycin Clindagel Clindamycin 1% / Hydrocortisone 2.5% / Niacinamide 4% NuCaraRXPAK Clindamycin Clindamycin 1% / Niacinamide 4% / Spironolactone 2% / Tretinoin 0.025% Clindacin ETZ Clindamycin and Benzoyl Peroxide Auro-clindamycin Clindamycin - Benzoyl Peroxide Clindamycin Phosphate Injection USP Liq Clindoxyl Gel M-clindamycin Cabtreo Clindamycin phosphate Clindamycin Phoaphate Topical Solution USP, 1% Clindamycin hydrochloride Onexton Clindamycin IV Infusion CLIN-LIDO-Single Use Kit ClindaReach Clinda-T Taro-clindamycin/benzoyl Peroxide Gel Clindamycin 1% / Niacinamide 4% / Tretinoin 0.025% ClindaMax Taro-benzoyl Peroxide / Clindamycin Kit Clindamycin Phosphate and Tretinion Clindamycin Phosphate and Tretinoin Clindacin Neuac Kit Adapalene 0.3% / Benzoyl Peroxide 2.5% / Clindamycin 1% Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 4% Clindamax Clindacin PAC Cleocin Phosphate Truemed Group LLC Benzoyl Peroxide 2.5% / Clindamycin 1% / Niacinamide 2% / Tretinoin 0.025% Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Spironolactone 2% / Tretinoin 0.025% Benzoyl Peroxide 5% / Clindamycin1% / Niacinamide 2% / Tretinoin 0.025% Ratio-clindamycin Capsules - 300mg Riva-clindamycin Nu-clindamycin Ag-clindamycin Taro-clindamycin Clinda-Derm Adapalene 0.1% / Benzoyl Peroxide 2.5% / Clindamycin 1% Clindamycin in 5 Percent Dextrose Imiquimod 5% / Levocetirizine Dihydrochloride 1% / Tretinoin 0.05% Cleocin Phosphate (0009-6582) (standalone) Biacna Topical Gel Clindamycin Hydrochloride Med-clindamycin CLIN-Single Use Kit Clindamycin Phoaphate Topical Solution, 1%
Indication	In oral and parenteral formulations, clindamycin is indicated for the treatment of serious infections caused by susceptible anaerobic bacteria, as well as susceptible staphylococci, streptococci, and pneumococci.[L11599,L11602] Used topically, it is indicated for the treatment of acne vulgaris[L11593,L11611,L11605] and is available in combination with [benzoyl peroxide][L11584] or [tretinoin][L11590] for this purpose, or as a triple combination therapy with benzoyl peroxide and [adapalene].[L48666] Clindamycin is also indicated as a vaginal cream[L11596], suppository[L11608], or gel[L39416] for the treatment of bacterial vaginosis in non-pregnant females. Clindamycin is used for antimicrobial prophylaxis against _Viridans_ group streptococcal infections in susceptible patients undergoing oral, dental, or upper respiratory surgery, and may be used for prophylaxis against bacterial endocarditis in penicillin-allergic patients at high risk of these infections.[L11629]
Categories	Agents that produce neuromuscular block (indirect) Anti-Acne Preparations Anti-Acne Preparations for Topical Use Anti-Bacterial Agents Anti-Infective Agents Antibacterials for Systemic Use Antibiotics for Pneumocystis Pneumonia Antiinfectives for Systemic Use Antiinfectives for Treatment of Acne Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (moderate) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Decreased Sebaceous Gland Activity Dermatologicals Enzyme Inhibitors Genito Urinary System and Sex Hormones Glycosides Gynecological Antiinfectives and Antiseptics Lincomycins Lincosamide Antibacterial Lincosamides Macrolides Macrolides, Lincosamides and Streptogramins Neuromuscular Blockade Neurotoxic agents P-glycoprotein substrates Protein Synthesis Inhibitors Pyrrolidines
ATC-Code	D10AF01 J01FF01 D10AF51 G01AA10
CAS number	18323-44-9

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
50S ribosomal protein L1	MAKKGKKYQEAASKVDRTQHYSVEEAIKLAKETSIANFDASVEVAFRLGI...	unknown	inhibitor
Cytochrome P450 3A5	MDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNV...	unknown	substrate
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate,inhibitor
Alpha-1-acid glycoprotein 1	MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDQITGKWFYIASAF...	unknown	substrate
P-glycoprotein 1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682